213 related articles for article (PubMed ID: 24728423)
1. Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers.
Zhou Z; Mondal M; Liao G; Guo Z
Org Biomol Chem; 2014 May; 12(20):3238-45. PubMed ID: 24728423
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse.
Wang Q; Zhou Z; Tang S; Guo Z
ACS Chem Biol; 2012 Jan; 7(1):235-40. PubMed ID: 22013921
[TBL] [Abstract][Full Text] [Related]
3. Development of Clickable Monophosphoryl Lipid A Derivatives toward Semisynthetic Conjugates with Tumor-Associated Carbohydrate Antigens.
Ziaco M; Górska S; Traboni S; Razim A; Casillo A; Iadonisi A; Gamian A; Corsaro MM; Bedini E
J Med Chem; 2017 Dec; 60(23):9757-9768. PubMed ID: 29045781
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Immunological Comparison of Differently Linked Lipoarabinomannan Oligosaccharide-Monophosphoryl Lipid A Conjugates as Antituberculosis Vaccines.
Wang L; Feng S; Wang S; Li H; Guo Z; Gu G
J Org Chem; 2017 Dec; 82(23):12085-12096. PubMed ID: 29112822
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of GM2-Monophosphoryl Lipid A Conjugate as a Fully Synthetic Self-Adjuvant Cancer Vaccine.
Zhou Z; Mandal SS; Liao G; Guo J; Guo Z
Sci Rep; 2017 Sep; 7(1):11403. PubMed ID: 28900154
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a monophosphoryl lipid A derivative and its conjugation to a modified form of a tumor-associated carbohydrate antigen GM3.
Wang Q; Xue J; Guo Z
Chem Commun (Camb); 2009 Oct; (37):5536-7. PubMed ID: 19753348
[TBL] [Abstract][Full Text] [Related]
7. Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants.
Rohokale R; Guo J; Guo Z
J Med Chem; 2024 May; 67(9):7458-7469. PubMed ID: 38634150
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a monophosphoryl derivative of Escherichia coli lipid A and its efficient coupling to a tumor-associated carbohydrate antigen.
Tang S; Wang Q; Guo Z
Chemistry; 2010 Jan; 16(4):1319-25. PubMed ID: 19943286
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant.
Gao L; Li G; Qiu C; Ye Y; Li X; Liao P; Ming W; Liu Z; Luo X; Liao G
J Med Chem; 2024 Jun; 67(12):9976-9990. PubMed ID: 38886162
[TBL] [Abstract][Full Text] [Related]
10. Recent development in carbohydrate-based cancer vaccines.
Guo Z; Wang Q
Curr Opin Chem Biol; 2009 Dec; 13(5-6):608-17. PubMed ID: 19766052
[TBL] [Abstract][Full Text] [Related]
11. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.
Mirshekar M; Haghighat S; Mousavi Z; Abdolghaffari AH; Yazdi MH
Immunol Res; 2024 Jun; 72(3):490-502. PubMed ID: 38383811
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines.
Li Q; Guo Z
Molecules; 2018 Jun; 23(7):. PubMed ID: 29966261
[TBL] [Abstract][Full Text] [Related]
13. Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.
Galonić DP; Gin DY
Nature; 2007 Apr; 446(7139):1000-7. PubMed ID: 17460660
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response.
Song C; Zheng XJ; Guo H; Cao Y; Zhang F; Li Q; Ye XS; Zhou Y
Glycoconj J; 2019 Oct; 36(5):399-408. PubMed ID: 31267246
[TBL] [Abstract][Full Text] [Related]
15. Optimized dose of synthetic analogues of Monophosphoryl lipid A as an effective alternative for formulating recombinant human papillomavirus vaccine.
Azimi A; Heidarian S; Zamani H; Taleghani N; Dehghani M; Seyedjafari E
Biologicals; 2020 Nov; 68():60-64. PubMed ID: 32859464
[TBL] [Abstract][Full Text] [Related]
16. Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo2-Monophosphoryl-Lipid A or Kdo2-Pentaacyl-Monophosphoryl-Lipid A.
Wang B; Han Y; Li Y; Li Y; Wang X
PLoS One; 2015; 10(12):e0144714. PubMed ID: 26710252
[TBL] [Abstract][Full Text] [Related]
17. Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice.
Chen PG; Hu HG; Sun ZY; Li QQ; Zhang BD; Wu JJ; Li WH; Zhao YF; Chen YX; Li YM
Mol Pharm; 2020 Feb; 17(2):417-425. PubMed ID: 31841011
[TBL] [Abstract][Full Text] [Related]
18. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
Wu J; Guo Z
Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
